TSPAN32 and myeloid sarcoma: The disruption of the control switch provided by TSPAN32 may be one of the possible promoters of the inflammatory damage to myelin, offering not only an important insight into the pathogenesis of MS, but also novel therapeutic targets that may underlie potential primary drivers of autoimmunity.